Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.31
-0.01-0.76%
Last update: Oct 6, 5:46 PM
$1.37
0.05324.03%
Cardiol Therapeutics Inc (CRDL) Stock Price, Quote, News & History
CRDLNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cardiol Therapeutics (NASDAQ:CRDL) through any online brokerage.
Other companies in Cardiol Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Cardiol Therapeutics has a consensus price target of $9.50.
The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $1.3732 last updated October 6, 2026 at 5:46 PM EDT.
There are no upcoming dividends for Cardiol Therapeutics.
Cardiol Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Cardiol Therapeutics.
Cardiol Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
